Aims: This article investigates the subjective experience of the process of improvement and recovery from the point of view of persons diagnosed (according to research diagnostic criteria) with schizophrenia and schizo-affective disorders.
Methods: A community study of persons using psychiatric services was conducted for a sample of ninety subjects taking atypical antipsychotic medications. Sociodemographic data and clinical ratings were collected to complement the qualitatively developed Subjective Experience of Medication Interview (SEMI), which elicits narrative data on everyday activities, medication and treatment, management of symptoms, expectations concerning recovery, stigma, and quality of life.
Results: Recovery was observed through: (1) relatively low ratings of psychiatrically observed symptomatology through BPRS scores; (2) the subjective sense among the majority (77.4%) of participants that taking medication plays a critical role in managing symptoms and avoiding hospitalization; and (3) the subjective sense articulated by the vast majority (80%) that they would recover from their illness and that the quality of their lives would improve (70.6%).
Conclusion: The overall quality of improvement and recovery is best characterized as an incremental, yet definitively discernable, subjective process.
Get full access to this article
View all access options for this article.
References
1.
ANDERSSON, C. , CHAKOS, M. , MAILMAN, R. & LIEBERMAN, J. (1998) Emerging roles for novel antipsychotic medications in the treatment of schizophrenia . Psychiatric Clinics of North America, 21, 151–179 .
2.
ANDREASEN, N.C. (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations . British Journal of Psychiatry, 155, 49–52 .
3.
AWAD, A.G. & HOGAN, T.P. (1994) Subjective response to neuroleptics and the quality of life: implications for treatment outcome . Acta Psychiatrica Scandinavica, 89, 27–32 .
4.
BEM, S.L. (1974) The measurement of psychological androgyny . Consulting & Clinical Psychology, 42, 155–162 .
5.
BREIER, A. , BUCHANAN, R.W. , IRISH, D. & CARPENTER, W.T. (2000) Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns . Psychiatric Services, 51, 1249–1253 .
6.
BUDD, R.J.H. , IAN, C.T. , & SMITH, J.A. (1996) Health beliefs and compliance with antipsychotic medication . British Journal of Clinical Psychology, 35, 393–397 .
7.
BURGER, G.K. , CALSYN, R.J. , MORSE, G.A. , KLINKENBERG, W.D. & TRUSTY, M.L. (1997) Factor structure of the expanded brief psychiatric rating scale . Journal of Clinical Psychology, 53, 451–454 .
8.
CHANG, E.C. (Ed.) (2001) Optimism and Pessimism: Implications for Theory, Research, and Practice. Washington, DC: American Psychological Association .
9.
COMMISSION ON MENTAL HEALTH (2003) Achieving the Promise: Transforming Mental Health Care in America. Executive Summary. DHHS Pub. No. SMA-03-3831. Rockville, MD: DHHS .
10.
CORRING, D. (2002) Quality of life: perspectives of people with mental illnesses and family members . Psychiatric Rehabilitation Journal, 25, 350–358 .
11.
COVELL, N.H. , FRISMAN, L.K. & ESSOCK, S.M. (2003). Rates of refusal to participate in research studies among men and women . Psychiatric Services, 54, 1541–1544 .
12.
CUFFEL, B.J. , ALFORD, J. , FISCHER, E.P. & OWEN, R.R. (1996) Awareness of illness in schizophrenia and outpatient treatment adherence . Journal of Nervous Mental and Disease, 184, 653–659 .
13.
DAVIDSON, L. (2003) Living Outside Mental Illness: Qualitative Studies of Recovery in Schizophrenia. New York: New York University Press .
14.
DAVIDSON, L. & STRAUSS, J.S. (1992) Sense of self in recovery from severe mental illness . British Journal of Medical Psychology, 65(2), 131–145 .
15.
DAVIDSON, L. , STAYNER, D.A. , NICKOU, C. , STYRON, T. , ROWE, M. & CHINMAN, M. (2001) ‘Simply to be let in’: inclusion as a basis for recovery . Psychiatric Rehabilitation Journal, 24, 375–388 .
16.
DEEGAN, P.E. (1988) Recovery: the lived experience of rehabilitation . Psychosocial Rehabilitation, 11, 11–19 .
17.
DINAKAR, H. , SOBEL, R. , BOPP, J.H. , DANIELS, A. & MAURO, S. (2002) E.cacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients . Psychiatric Services, 53, 755–757 .
18.
FIRST, M.B. , SPITZER, R.L. , GIBBON, M. & WILLIAMS, J.B.W. (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute .
19.
FLOERSCH, J. (2002) Meds, Money, and Manners: The Case Management of Mental Illness. New York: Columbia University Press .
20.
FRESE, F.J. (2001) Integrating evidence-based practices and the recovery model . Psychiatric Services, 52, 1462–1468 .
21.
GEERTZ, C. (1984) On the nature of anthropological understanding. In Culture Theory: Essays on Mind, Self, and Emotion. (eds. R.A. Shweder & R.A. LeVine ). Cambridge: Cambridge University Press .
22.
GOLDSTEIN, J.M. (1988) Gender di.erences in the course of schizophrenia . American Journal of Psychiatry, 145, 684–689 .
23.
GOOD, B.J. (1994) Medicine, Rationality, and Experience: An Anthropological Perspective. Cambridge and New York: Cambridge University Press .
24.
HARRISON, G. , HOPPER, K. , CRAIG, T. , LASKA, E. , SIEGAL, C. & WANDERLING, J. (2001) Recovery from psychotic illness: a 15 and 25-year international follow-up study . British Journal of Psychiatry, 178, 506–517 .
25.
HOGAN, T.P. & AWAD, A.G. (1992) A self-report scale predictive of drug compliance in schizophrenics: a re-examination comparing two measures . Psychological Medicine, 22, 347–352 .
26.
HOGARTY, G. (2002) Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment. New York: Guilford Press .
27.
HOLLINGSHEAD, A. (n.d) Four Factor Index of Social Status. Yale University, Department of Sociology, New Haven: Unpublished manuscript.
28.
HOPPER, K. (2004) Interrogating the meaning of ‘culture’ in WHO international studies of schizophrenia. In Schizophrenia, Culture, and Subjectivity: The Edge of Experience (eds. J.H. Jenkins & R.J. Barrett ). New York: Cambridge University Press .
29.
JACOBSON, N. (2001a) Experiencing recovery: a dimensional analysis of recovery narratives . Psychiatric Rehabilitation Journal, 24, 248–256 .
30.
JACOBSON, N. (2001b) What is recovery?A conceptual model and explication. Psychiatric Services, 52, 482–485 .
31.
JENKINS, J.H. (1988) Ethnopsychiatric interpretations of schizophrenic illness: the problem of nervios within Mexican-American families . Culture, Medicine and Psychiatry, 12, 301–329 .
32.
JENKINS, J.H. (1997) Subjective experience of persistent psychiatric disorder: schizophrenia and depression among U.S. Latinos and Euro-Americans . British Journal of Psychiatry, 170, 20–25 .
33.
JENKINS, J.H. (2004) Schizophrenia as a paradigm case for understanding fundamental human processes. In Schizophrenia, Culture, and Subjectivity: The Edge of Experience. (eds. J.H. Jenkins & R.J. Barrett ). New York: Cambridge University Press .
34.
JENKINS, J.H. & BARRETT, R.J. (2004) (eds.) Schizophrenia, Culture, and Subjectivity: The Edge of Experience. New York: Cambridge University Press .
35.
JENKINS, J.H. & KARNO, M. (1992) The meaning of ‘expressed emotion’: theoretical issues raised by crosscultural research . American Journal of Psychiatry, 149, 9–21 .
36.
JENKINS, J.H. & SCHUMACKER, J.G. (1999) Family burden of schizophrenia and depressive illness: specifying the e.ects of ethnicity, gender, and social ecology . British Journal of Psychiatry, 174, 31–38 .
37.
KARNO, M.JENKINS, J.H. , DE LA SELVA, A. , SANTANA, F. , TELLES, C. & LOPEZ, S. (1987) Expressed emotion and schizophrenic outcome among Mexican-American families . Journal of Nervous and Mental Disorders, 175, 143–151 .
38.
KLEINMAN, A. (1988) The Illness Narratives: Su.ering, Healing, and the Human Condition. New York: Basic Books .
39.
KRAEPELIN, E. (1919) Dementia Praecox and Paraphrenia. Edinburgh: E. & S. Livingstone .
40.
LEFF, J. & VAUGHN, C. (1985) Expressed Emotion in Families. New York: Guilford Press .
41.
LENROOT, R. , BUSTILLO, J.R. , LAURIELLO, J. & KEITH, S.J. (2003) Integration of care: Integrated treatment of schizophrenia . Psychiatric Services, 54, 1499–1507 .
42.
LIBERMAN, R.P. , KOPELOWICZ, A. , VENTURA, J. & GUTKIND, D. (2002) Operational criteria and factors related to recovery from schizophrenia . International Review of Psychiatry, 14, 256–272 .
43.
LIEBERMAN, J.A. , TOLLEFSON, J.A. , TOHEN, M.GREEN, A.I. , GUR, R.E. & KAHN, R. (2003) Comparative E.cacy of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: a Randomized, Double-Blind Trial of Olanzapine versus Haloperidol . American Journal of Psychiatry, 160, 1396–1404 .
44.
LIN, M. & KLEINMAN, A. (1988) Psychopathology and clinical course of schizophrenia: a cross-cultural perspective . Schizophrenia Bulletin, 4, 555–567 .
45.
LUBORSKY, M.R. (1993) The identi.cation and analysis of themes and patterns. In Qualitative Methods in Aging Research. (ed. J. Gubrium & A. Snakar ). New York: Sage Publications .
46.
MARKOWITZ, F. (2001) Modelling processes in recovery from mental illness: relationships between symptoms, life satisfaction, and self-concept . Journal of Health and Social Behavior, 42, 64–79 .
47.
MEDDINGS, S. & PERKINS, S. (2002) What ‘getting better’ means to sta. and users of a rehabilitation service: an exploratory study . Journal of Mental Health, 11, 319–325 .
48.
MORTIMER, A.M. (2003) Antipsychotic treatment in schizophrenia: atypical options and NICE guidance . European Psychiatry, 18, 209–219 .
49.
MUESER, K.T. , CORRIGAN, P.W. , HILTON, D.W. , TANZMAN, B. , SCHAUB, A. & GINGERICH, S. (2002) Illness management and recovery: a review of the research . Psychiatric Services, 53, 1272–1284 .
50.
NATIONAL INSTITUTE OF HEALTH (2001) Qualitative methods in health research: Opportunities and considerations in application and review. Bethesda: NIH .
51.
NOORDSY, D. , TORREY, W. , MUESER, K. , MEAD, S. , O'KEEFE, C. & FOX, L. (2002) Recovery from severe mental illness: an intrapersonal and functional outcome de.nition . International Review of Psychiatry, 14, 318–326 .
RIDGWAY, P. (2001) Restorying psychiatric disability: learning from .rst person recovery narratives . Psychiatric Rehabilitation Journal, 24, 335–343 .
54.
ROSENHECK, R. , TEKELL, J. , PETERS, J. , CRAMER, J. , FONTANA, A. & XU, W. (1998) Does participation in psychosocial treatment augment the bene.t of clozapine?Archives of General Psychiatry, 55, 618–625 .
55.
SAJATOVIC, M. , JENKINS, J. , STRAUSS, M. , BUTT, Z. & CARPENTER, E. (2005). Gender identity among men and women with schizophrenia . Psychiatric Services, 56(1), 96–98 .
56.
SALOKANGAS, R.K. (1997) Living situation, social network and outcome in schizophrenia: a .ve-year prospective follow-up study . Acta Psychiatrica Scandinavica, 96, 459–468 .
57.
SCIENTIFIC SOFTWARE DEVELOPMENT (1997) ATLAS/ti. Berlin, Germany.
58.
SEEMAN, M. (1995) Gender and Psychopathology. Washington, DC: American Psychiatric Press .
59.
SHWEDER, R.A. & BOURNE, E.J. (1984) Does the concept of the person vary cross-culturally? In Culture Theory: Essays on Mind, Self, and Emotion (ed. R.A. Shweder & R.A. LeVine ). Cambridge: Cambridge University Press .
60.
SPANIOL, L.WEWIORSKI, N.J. , GAGNE, C. & ANTHONY, W.A. (2002) The process of recovery from schizophrenia . International Review of Psychiatry, 14, 327–336 .
61.
STRAUSS, J.S. & CARPENTER, W.T. (1977) Prediction of outcome in schizophrenia III: .ve-year outcome and its predictors . Archives of General Psychiatry, 34, 159–163 .
62.
TOHEN, M.STRAKOWSKI, S.M. & ZARATE, C. (2000) The McLean-Harvard .rst-episode project: 6-month symptomatic and functional outcome in a.ective and nona.ective psychosis . Biological Psychiatry, 48, 467–476 .
63.
TORGALSBOEN, A.K. & RUND, B.R. (1998) ‘Full recovery’ from schizophrenia in the long term: a ten-year follow up of eight former schizophrenic patients . Psychiatry, 61, 20–34 .
64.
TURNER-CROWSON, J. & WALLCRAFT, W. (2002) The recovery vision for mental health services and research: a British perspective . Psychiatric Rehabilitation Journal, 25, 245–254 .
65.
VELLIGAN, D.I. , LAM, F. , ERESHEFSKY, L. & MILLER, A.L. (2003) Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications . Psychiatric Services, 54, 665–667 .
66.
WARNER, R. (1994) Recovery from Schizophrenia. New York: Routledge .
67.
WASERMAN, J. & CRIOLLO, M. (2000) Subjective experiences of clozapine treatment by patients with chronic schizophrenia . Psychiatric Services, 51, 666–668 .
68.
WEIDEN, P. , AQUILA, R. , & STANDARD, J. (1996) Atypical antipsychotic drugs and long-term outcome in schizophrenia . Journal of Clinical Psychiatry, 57(Suppl. 11), 53–60 .
69.
WEIDEN, P. , RAPKIN, B. , MOTT, T. , et al. (1994) Rating of Medication In.uences (ROMI) scale in schizophrenia . Schizophrenia Bulletin, 20, 297–310 .
70.
WORLD HEALTH ORGANIZATION (1998) Schizophrenia and Public Health. Geneva: World Health Organization .
71.
WORLD HEALTH ORGANIZATION (1979) Schizophrenia: an International Follow-up Study. Chichester: John Wiley and Sons .
